73 1 / 3 Pef. MD 105/2018 14th November 2018. Subj Management Discussion and Analysis (MD&A) Q3/2018 Dear Managing Director of Stock Exchange of Thailand We, Patum Rice Mill and Granary Public
วันที่ 14 สิงหาคม 2550 DEMCO Public Company Limited No. Demco AC005/2018 November 14, 2018 Subject : The company’s operating result of the 3rd quarter of year 2018. To : The president, The Stock
Microsoft Word - MDA_2018Q3_ENG 1 Ref: CK-18-0000-AFD(AC)-L-0050 November 14, 2018 Subject: Clarification on Operating Result and Financial Position for the nine-month ended September 30, 2018
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” November 14, 2018 Subject: Clarification on the cause of changes in operating results. To: Director and Manager The Stock
Translation CEN 034-2018 November 13, 2018 Subject : Management Discussion and Analysis for quarter 3-2018 To : The Manager and President The Stock Exchange of Thailand Business operation for 3
Microsoft Word - Oishi MDA - Year End 2018_EN_v2_Sud.docx Ref. SorNor. 040/2018 November 20, 2018 Subject: Clarification of Operating Results and Financial Status for the year 2018, ended September
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.172/2018 30 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which
to the Board Meeting of Osotspa Public Company Limited (“the Company”) No. 11/2018 on 14 November 2018, the Board resolved to approve in principle the investment, through Oventure Pte. Ltd. which is a
Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_OCS/009/2019 Date November 4
Acc. 006/2019 November 11, 2019 To: The President The Stock Exchange of Thailand Subject: Management discussion and analysis (MD&A) for Quarter 3/2019 Dear Sir, S. Khonkaen Foods Public Company